A central function for perlecan in skeletal muscle and cardiovascular development - Test2 - elhamkhani - TriplyDB

A central function for perlecan in skeletal muscle and cardiovascular development

A central function for perlecan in skeletal muscle and cardiovascular development

http://www.wikidata.org/entity/Q24648227

about

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy Decoding the Matrix: Instructive Roles of Proteoglycan Receptors Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease A current view of perlecan in physiology and pathology: A mosaic of functions.A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis.Mtmr8 is essential for vasculature development in zebrafish embryos.Embryonic mouse blood flow and oxygen correlate with early pancreatic differentiation The Popeye domain containing 2 (popdc2) gene in zebrafish is required for heart and skeletal muscle development.Endorepellin evokes autophagy in endothelial cells NGS nominated CELA1, HSPG2, and KCNK5 as candidate genes for predisposition to Balkan endemic nephropathy Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.Blood vessel repair and regeneration in the ischaemic heart Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.Collagen type IV and Perlecan exhibit dynamic localization in the Allantoic Core Domain, a putative stem cell niche in the murine allantois Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro The proteoglycan Trol controls the architecture of the extracellular matrix and balances proliferation and differentiation of blood progenitors in the Drosophila lymph gland Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish.Endorepellin affects angiogenesis by antagonizing diverse vascular endothelial growth factor receptor 2 (VEGFR2)-evoked signaling pathways: transcriptional repression of hypoxia-inducible factor 1α and VEGFA and concurrent inhibition of nuclear fact Laminin-211 in skeletal muscle function.The role of extracellular matrix in vascular branching morphogenesis Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept.Diverse cell signaling events modulated by perlecan.In vitro and in vivo characterization of the anticancer activity of Thai stingless bee (Tetragonula laeviceps) cerumen The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.Force measurement during contraction to assess muscle function in zebrafish larvae.Soft texture of atlantic salmon fillets is associated with glycogen accumulation.EphA2 is a functional receptor for the growth factor progranulin.Basement membrane components are key players in specialized extracellular matrices.Urinary biomarkers of physical activity: candidates and clinical utility.The cardiovascular triad of dysfunctional angiogenesis.The nature and biology of basement membranes.Endorepellin-evoked Autophagy Contributes to Angiostasis.At the Start of the Sarcomere: A Previously Unrecognized Role for Myosin Chaperones and Associated Proteins during Early Myofibrillogenesis.

P2860

Q21710680-37587862-E9C7-4DE6-B02D-D72BA7F2122B Q24303934-456BD01F-96B8-4CC8-851B-F39A6B740DE0 Q24312922-6FA6EC73-5EC1-4E06-A17C-09825D65C463 Q24653433-7A61598D-3341-4263-B330-0011FB4C8090 Q26800258-711C63EC-9AB0-4E0B-A694-2F68FAB9A686 Q26801397-04994B5F-847B-48FB-A836-3F87D5B5C76B Q28087402-1A43EA9E-274E-4508-BCF2-803C83AE7CEB Q30392738-F1589E89-DB01-4644-BAC5-B226FA2902EE Q30489730-37E26B9C-536C-4838-9893-B451A4201DB6 Q30496686-8B06A0EA-8B46-4475-ADBD-1580A4827F31 Q30497859-09B717DC-C140-4FD6-9679-9F1BC4098DDF Q30540461-92100349-DCC3-4667-AD6A-1D613C8E3031 Q33718473-A630B69E-6516-46EC-B3B5-F420E6A62ECA Q33735983-DFE8B8F2-0CBB-4044-85EC-2C08FBF432BB Q34126666-ECE82AA9-0827-41BA-9D99-20F1C411DDFE Q34304413-E1BC2AFF-AAB6-480D-8961-08770CD12FFD Q34439113-44704C0E-89FD-412E-911F-CDCA2AF68A92 Q34512935-709D62CC-DB0C-40E1-8B80-0EE77422E4E3 Q34548326-CCB21F6B-8550-467E-BA8D-9762E847B255 Q34783479-AB1329A9-D927-47E9-9822-596557B84CEE Q35773980-F202D331-5AC5-4459-A01A-E0E666EF2A0B Q35806361-F2AC5AF1-AF73-436F-8CE6-831BEDD798C6 Q36481790-9CB68201-F2D0-4896-B12B-03F708D2A7AC Q36531788-0D0D70B7-060D-4D57-A349-9C004A4E46B1 Q36542074-D5C24151-E560-45ED-A26B-96147E7E1A77 Q36578668-FCF1B75E-764A-4259-AE5B-F08FD8DCC2CF Q36787608-79F17C9B-0FDC-4B48-A15C-6E9759A28161 Q36884215-DEBFF517-9346-47BA-80FC-303076A62657 Q37020797-7741FB21-AE4B-41E8-BB5A-79CFBC585CC3 Q37071520-E200B111-0FEE-438E-AFDB-76223753D611 Q37271260-1EA18FBA-E144-4CAC-9D66-2FAD2529F73B Q37354921-0EFF3B8E-F016-4801-98C3-7FF975EF37EE Q37458773-BDACCFE1-A461-4246-BF3A-9A474541BE1D Q37488302-393CDB9B-97C7-4CC9-931F-8368938537AC Q37739297-94C2EE4E-67BF-47C1-AE4A-3A26BC4C94BD Q38172265-223D235A-27C4-49C9-AC17-FE8A17AC86ED Q38281725-5FEA62F7-5F42-4F3E-B571-EDB7144C379A Q39063783-DE19A2F3-23E5-40A1-9562-C89EDD961ADF Q41049426-A3670871-E9BD-4CF1-A87F-3A59FB7EB3CD Q41570390-B7D43F40-1A5F-4414-A6B0-1F41713B2719

P2860

A central function for perlecan in skeletal muscle and cardiovascular development

http://www.wikidata.org/entity/Q24648227

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A central function for perlecan in skeletal muscle and cardiovascular development

@ast

A central function for perlecan in skeletal muscle and cardiovascular development

@en

A central function for perlecan in skeletal muscle and cardiovascular development

@nl

type

label

A central function for perlecan in skeletal muscle and cardiovascular development

@ast

A central function for perlecan in skeletal muscle and cardiovascular development

@en

A central function for perlecan in skeletal muscle and cardiovascular development

@nl

prefLabel

A central function for perlecan in skeletal muscle and cardiovascular development

@ast

A central function for perlecan in skeletal muscle and cardiovascular development

@en

A central function for perlecan in skeletal muscle and cardiovascular development

@nl

P1433

Q24648227-82FA8B19-ACAC-44A5-A278-591DBE042CBD

P1476

Q24648227-BF903149-F118-431D-9074-8DB2E31B65D7

P2093

Q24648227-B91D12D8-AFB3-4533-986B-2B22063F6360

Q24648227-CDE56A70-4D14-4778-A8C8-7FD9F028BA0B

Q24648227-FFFD4E6E-2B4F-49B3-83F5-463DBC4F13CA

P2860

Q24648227-0064F692-4E6F-4C11-A362-9FFC47969795

Q24648227-00E56EFC-54AB-445C-9E9A-98DB62608C19

Q24648227-019A5FF5-ADE4-42F2-8CB7-34511FA6DBA6

Q24648227-02946D1E-F06C-4A3C-92E1-872785D12C03

Q24648227-02CFEBB5-0D7B-4B6B-99EA-40B97C088DCD

Q24648227-05EBB9F2-380B-4FFA-AFAD-DB3AF65F9BAC

Q24648227-10C9484B-E4FA-46CE-8349-D90B6EB4AF1F

Q24648227-199EC1F9-0126-4FEF-920E-83AFEFE62A70

Q24648227-24E428ED-833F-4614-89D8-3CBC9F477903

Q24648227-270F93B6-D20E-44BF-B602-8181478111B1

P304

Q24648227-A8E54B78-8E0D-4339-BF06-CA4D6E0D7AFE

P31

Q24648227-63FBF5C4-D4BD-4BD5-A885-69B64F7891B8

P356

Q24648227-2B3D77F5-3448-416C-A5CA-8FA16E13BA51

P407

Q24648227-AF8B6D6F-0D1B-47BC-9A50-7E1009EA136F

P433

Q24648227-EE49A906-43DE-4EC3-AD20-F6CBA07AB33A

P478

Q24648227-23781868-8532-4A9B-BED5-603A4AC54E52

P50

Q24648227-2C462CA8-0DD7-4086-9F79-EE8744214E2C

Q24648227-49846CE9-718B-4F31-A6F5-84C676CA1B0C

P577

Q24648227-E06FC7C3-C182-416D-99FF-28BD7697FD0F

P5875

Q24648227-1ABD504D-5531-40A5-A237-D43788A048C3

P698

Q24648227-482F71D5-87D5-43C9-A4BB-03789CEAFA3F

P921

Q24648227-664D805F-1412-4F8E-B88E-1CA62DECF166

Q24648227-FFBACA73-4F8B-4822-8853-2E58313F0C2C

P932

Q24648227-060BCC4C-9D1E-41F8-AE46-17F04DE8A806

P356

P1433

Journal of Cell Biology

P1476

A central function for perlecan in skeletal muscle and cardiovascular development

@en

P2093

Angela McQuillan

http://www.w3.org/2001/XMLSchema#string

Jason J Zoeller

http://www.w3.org/2001/XMLSchema#string

Shiu-Ying Ho

http://www.w3.org/2001/XMLSchema#string

P2860

p53 activation by knockdown technologies

Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

Perlecan maintains the integrity of cartilage and some basement membranes

Perlecan is essential for cartilage and cephalic development

Role of perlecan in skeletal development and diseases

Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan

A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells

Developmental expression of perlecan during murine embryogenesis

P304

381-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200708022

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P50

Renato V. Iozzo

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5425866

http://www.w3.org/2001/XMLSchema#string

P698

18426981

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2315682

http://www.w3.org/2001/XMLSchema#string